Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Qmed

This article was originally published in The Gray Sheet

Executive Summary

Qmed: Appoints Howard Waltham as chairman of the board, replacing company founder Michael Cox, who will continue as Qmed president and CEO. From 1985 to 1995, Waltham served as chairman and CEO of Sanus Corp. Health System, a national HMO company. In early May, Qmed finalized a strategic alliance with SmithKline Beecham under which SKB obtained exclusive rights to market and sell Qmed's ohms/cad (on-line health management system for coronary artery disease) to U.S. managed care companies in return for an equity investment -- 177,777 shares of Qmed common stock at $11.25 per share -- from SKB's venture capital affiliate S.R. One, Ltd. S.R. One also obtained a warrant to acquire an additional 63,492 shares of Qmed common at $15.75 per share...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts